Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Even with the best of news, late breaker, AMARIN still manages to tank. As always.
That's extremely small. Don't expect US market will react the same.
Hi Meow,
Do we have gV sales data now?
Why GILD? Have they express their interest?
Why is it tanking again? I think AMRN gonna be $4-5 stock for a long time. Bad karma?
But this is AMARIN we are talking about. They might need to change their name to “Murphy”.
Hi Sleven,
Who will be the jurors?
Amarin must have done bad things in its previous life.
Are you saying that Mochida might want Hikma to pay for the license too?
Good results/news/forecast = Stock sell-off and valuation drop usually for AMRN...
I don't put high hope to AMRN luck anymore. A string of bad karma/luck. This company is jinxed.
@bg, First, not all V users are here, maybe only <5%. Second, not 100% of V users who happen to be here and saw the polls were exposed to COVID-19. Third, no data whether those taking V are also wearing mask all the time when outside and practice social distancing or not.
Could be all V user here are also a very responsible human who practice social distancing and wear mask all the time.
Exactly. The current price it too low. Doesn't justify 5x-6x premium.
Or rather $6?
$6 will be 50% "premium" from the current price. It could get approved... :(
Or taken private since they kept boasting about their $600M cash. Taken private with $5/share will be a disaster.
This is flawed and meaningless statistics. Not 100% of people are getting COVID, and maybe all those people replying are not even exposed to COVID, thanks to God for that. Please keep practicing social distancing.
Yeah. If I were to put all AMRN holding to XPEV or NIO or LI, could have gained all back or even more.
Any reference article?
I could not find the 600 or 800 mg specification in the MSDS.
What’s up with 5% drop pre market today?!?
And will this mean it's more than 10% (assumed population with TG>500)?
Always like that with $AMRN. Whack-a-mole share price. From 27% up pre-market, now only less than 1/10 of it.
Are we expecting any PACER update?
Hi Invest,
Thank you for the update. Not bad considering the circumstances.
Hi Invest,
Do you know whether BB has reported their current holding in AMRN?
Thank you.
Still stock price dropped 7% today
Why haven't they (Baker Brothers) sold AMRN? The stock price dropped another 7% today after gV announcement,
Is this appeal still active?
Eventually, they will figure it out.
Useless since en banc is rejected, as expected, and Hikma launches the gV.
So we know, there is nothing done from JT/Amarin, no settlement, no nothing. Just a bunch of executives milking and cash in from their stocks entitlement.
They also stated this indication:
"Hikma’s FDA-approved Icosapent Ethyl Capsule product is indicated for the following indication: as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. Hikma’s product is not approved for any other indication for the reference listed drug VASCEPA®."
And Hikma immediately launch their gV
https://www.nasdaq.com/articles/hikma-pharma-launches-icosapent-ethyl-capsules-in-u.s.-quick-facts-2020-11-05
Apparently, they have been waiting only for the en banc news, and was not deterred by the ruling for GSK vs Teva!!!
The pre-market price will crash again.
You have been holding it since 2002?
What is the implication of this patent to be added in the Orange Book?
There are currently 163 records, 10 pending, only 1 moot, the rest 152 DENIED.... We know what's AMRN chance in this, close to zero %.
Nice reply. :)
When is the en banc decision? 99% it's going to be rejected BTW.